Karl Bayer
Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 69 | 2025 | 175 | 21.270 |
Why?
| Long-Term Potentiation | 23 | 2025 | 180 | 8.120 |
Why?
| Receptors, N-Methyl-D-Aspartate | 25 | 2025 | 209 | 6.110 |
Why?
| Hippocampus | 31 | 2025 | 797 | 3.830 |
Why?
| Long-Term Synaptic Depression | 9 | 2023 | 55 | 3.520 |
Why?
| Synapses | 17 | 2024 | 386 | 3.380 |
Why?
| Phosphorylation | 39 | 2025 | 1709 | 2.930 |
Why?
| Memory | 6 | 2024 | 231 | 2.850 |
Why?
| Calcium | 21 | 2024 | 1189 | 2.600 |
Why?
| Neurons | 23 | 2025 | 1454 | 2.110 |
Why?
| Neuronal Plasticity | 9 | 2025 | 263 | 2.090 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 14 | 2011 | 181 | 2.010 |
Why?
| Death-Associated Protein Kinases | 3 | 2021 | 10 | 1.980 |
Why?
| Glutamic Acid | 9 | 2023 | 232 | 1.860 |
Why?
| Calmodulin | 10 | 2019 | 75 | 1.480 |
Why?
| Neuroprotective Agents | 4 | 2025 | 111 | 1.450 |
Why?
| Rats | 34 | 2025 | 5285 | 1.340 |
Why?
| Animals | 63 | 2025 | 35076 | 1.280 |
Why?
| Heart Arrest | 3 | 2021 | 328 | 1.180 |
Why?
| Protein Binding | 19 | 2025 | 2120 | 1.140 |
Why?
| Dendritic Spines | 4 | 2024 | 60 | 1.090 |
Why?
| Amyloid beta-Peptides | 3 | 2025 | 214 | 1.050 |
Why?
| Cell Death | 5 | 2021 | 353 | 1.020 |
Why?
| Ischemia | 3 | 2020 | 399 | 0.990 |
Why?
| HEK293 Cells | 9 | 2025 | 686 | 0.980 |
Why?
| Cyclopentanes | 1 | 2025 | 19 | 0.960 |
Why?
| Receptors, Metabotropic Glutamate | 2 | 2022 | 40 | 0.880 |
Why?
| Brain Ischemia | 2 | 2021 | 309 | 0.880 |
Why?
| Learning | 2 | 2024 | 391 | 0.860 |
Why?
| Rats, Sprague-Dawley | 17 | 2020 | 2321 | 0.830 |
Why?
| Amino Acid Sequence | 14 | 2019 | 2060 | 0.810 |
Why?
| Mice | 21 | 2024 | 16832 | 0.760 |
Why?
| Protein Processing, Post-Translational | 4 | 2019 | 451 | 0.750 |
Why?
| Electrophysiological Phenomena | 1 | 2021 | 52 | 0.720 |
Why?
| CA1 Region, Hippocampal | 1 | 2021 | 47 | 0.710 |
Why?
| Protein Kinase Inhibitors | 8 | 2018 | 883 | 0.710 |
Why?
| Alternative Splicing | 5 | 2006 | 219 | 0.690 |
Why?
| N-Methylaspartate | 9 | 2022 | 36 | 0.680 |
Why?
| Holoenzymes | 2 | 2021 | 21 | 0.650 |
Why?
| Disks Large Homolog 4 Protein | 1 | 2019 | 16 | 0.640 |
Why?
| Cerebral Cortex | 3 | 2021 | 419 | 0.630 |
Why?
| Nitric Oxide | 2 | 2014 | 896 | 0.630 |
Why?
| Mutation | 9 | 2020 | 3723 | 0.630 |
Why?
| Brain | 7 | 2019 | 2629 | 0.620 |
Why?
| Peptides | 6 | 2023 | 917 | 0.610 |
Why?
| Post-Synaptic Density | 6 | 2016 | 11 | 0.610 |
Why?
| Lipoylation | 1 | 2017 | 18 | 0.580 |
Why?
| Cells, Cultured | 13 | 2021 | 4106 | 0.580 |
Why?
| Green Fluorescent Proteins | 6 | 2025 | 394 | 0.560 |
Why?
| Synaptic Transmission | 3 | 2019 | 261 | 0.560 |
Why?
| Adenosine Diphosphate | 3 | 2015 | 79 | 0.550 |
Why?
| Protein Transport | 8 | 2019 | 429 | 0.550 |
Why?
| Molecular Sequence Data | 12 | 2014 | 2854 | 0.550 |
Why?
| A Kinase Anchor Proteins | 1 | 2017 | 71 | 0.540 |
Why?
| Excitatory Amino Acid Agonists | 3 | 2014 | 39 | 0.540 |
Why?
| Spine | 1 | 2017 | 158 | 0.510 |
Why?
| Adenosine Triphosphate | 4 | 2013 | 483 | 0.510 |
Why?
| Microscopy, Fluorescence | 3 | 2015 | 405 | 0.480 |
Why?
| Second Messenger Systems | 1 | 2014 | 32 | 0.460 |
Why?
| Models, Molecular | 8 | 2019 | 1486 | 0.460 |
Why?
| Protein Conformation | 7 | 2021 | 857 | 0.430 |
Why?
| Carrier Proteins | 6 | 2016 | 738 | 0.430 |
Why?
| Membrane Proteins | 1 | 2019 | 1121 | 0.400 |
Why?
| Mice, Inbred C57BL | 7 | 2024 | 5365 | 0.400 |
Why?
| Protein Interaction Mapping | 2 | 2019 | 109 | 0.400 |
Why?
| Actin Cytoskeleton | 3 | 2016 | 104 | 0.400 |
Why?
| Protein Isoforms | 4 | 2018 | 379 | 0.380 |
Why?
| Autophagy | 1 | 2014 | 269 | 0.370 |
Why?
| Nucleotides | 1 | 2011 | 118 | 0.350 |
Why?
| Drug Design | 1 | 2011 | 157 | 0.350 |
Why?
| Actins | 4 | 2016 | 409 | 0.350 |
Why?
| Receptors, AMPA | 3 | 2024 | 134 | 0.350 |
Why?
| Humans | 31 | 2025 | 130305 | 0.340 |
Why?
| Transfection | 5 | 2017 | 910 | 0.340 |
Why?
| Nerve Tissue Proteins | 4 | 2019 | 572 | 0.340 |
Why?
| Protein Domains | 4 | 2019 | 252 | 0.340 |
Why?
| Substrate Specificity | 4 | 2014 | 373 | 0.340 |
Why?
| Peptide Fragments | 4 | 2018 | 698 | 0.320 |
Why?
| Cell Line | 8 | 2011 | 2786 | 0.320 |
Why?
| Isoenzymes | 5 | 2014 | 305 | 0.320 |
Why?
| Gene Expression Regulation, Enzymologic | 4 | 2018 | 290 | 0.310 |
Why?
| Mice, Knockout | 3 | 2021 | 2811 | 0.310 |
Why?
| Neuroprotection | 2 | 2020 | 33 | 0.300 |
Why?
| Benzylamines | 5 | 2013 | 42 | 0.270 |
Why?
| Cell Nucleus | 3 | 2012 | 580 | 0.270 |
Why?
| Excitatory Postsynaptic Potentials | 2 | 2016 | 113 | 0.230 |
Why?
| Enzyme Activation | 6 | 2017 | 817 | 0.230 |
Why?
| Ionomycin | 2 | 2019 | 24 | 0.230 |
Why?
| Biological Products | 1 | 2007 | 203 | 0.230 |
Why?
| Binding Sites | 4 | 2014 | 1252 | 0.220 |
Why?
| Protein Kinases | 1 | 2006 | 307 | 0.220 |
Why?
| Signal Transduction | 7 | 2014 | 4930 | 0.220 |
Why?
| D-Aspartic Acid | 1 | 2023 | 2 | 0.210 |
Why?
| Male | 16 | 2024 | 63748 | 0.210 |
Why?
| Sarcoplasmic Reticulum | 2 | 2003 | 44 | 0.210 |
Why?
| Sulfonamides | 5 | 2013 | 502 | 0.200 |
Why?
| Receptors, Adrenergic, beta | 1 | 2023 | 127 | 0.200 |
Why?
| Optogenetics | 1 | 2023 | 114 | 0.190 |
Why?
| Nucleus Accumbens | 2 | 2013 | 128 | 0.190 |
Why?
| Cell Hypoxia | 2 | 2015 | 239 | 0.190 |
Why?
| Protein Subunits | 2 | 2013 | 232 | 0.190 |
Why?
| Embryo, Mammalian | 2 | 2015 | 227 | 0.180 |
Why?
| Single Molecule Imaging | 2 | 2021 | 35 | 0.180 |
Why?
| Animals, Newborn | 3 | 2014 | 822 | 0.180 |
Why?
| Swine | 1 | 2023 | 744 | 0.170 |
Why?
| Neural Inhibition | 2 | 2012 | 152 | 0.170 |
Why?
| Spodoptera | 3 | 2009 | 37 | 0.170 |
Why?
| Neurotoxins | 1 | 2020 | 27 | 0.170 |
Why?
| Enzyme Inhibitors | 6 | 2015 | 832 | 0.170 |
Why?
| Point Mutation | 2 | 2014 | 227 | 0.170 |
Why?
| Action Potentials | 2 | 2014 | 472 | 0.160 |
Why?
| Protective Agents | 1 | 2019 | 38 | 0.160 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2006 | 825 | 0.160 |
Why?
| Recombinant Fusion Proteins | 3 | 2010 | 645 | 0.160 |
Why?
| Protein Structure, Tertiary | 2 | 2014 | 842 | 0.160 |
Why?
| Female | 8 | 2021 | 68842 | 0.160 |
Why?
| Nervous System | 1 | 1999 | 67 | 0.160 |
Why?
| Purkinje Cells | 1 | 2019 | 67 | 0.160 |
Why?
| Multigene Family | 1 | 2019 | 200 | 0.150 |
Why?
| RNA, Messenger | 3 | 2018 | 2732 | 0.150 |
Why?
| Mutation, Missense | 2 | 2014 | 321 | 0.150 |
Why?
| Mutagenesis | 2 | 2011 | 181 | 0.150 |
Why?
| Movement | 1 | 2020 | 270 | 0.150 |
Why?
| Resuscitation | 1 | 2020 | 244 | 0.140 |
Why?
| Kinetics | 2 | 2011 | 1634 | 0.140 |
Why?
| Exons | 1 | 2018 | 336 | 0.140 |
Why?
| Membrane Potentials | 2 | 2014 | 266 | 0.130 |
Why?
| Blotting, Western | 3 | 2009 | 1201 | 0.130 |
Why?
| Organ Culture Techniques | 1 | 2016 | 146 | 0.130 |
Why?
| Alzheimer Disease | 2 | 2019 | 519 | 0.130 |
Why?
| Mice, Mutant Strains | 1 | 2016 | 295 | 0.130 |
Why?
| Proteins | 1 | 2001 | 948 | 0.130 |
Why?
| Dose-Response Relationship, Drug | 5 | 2013 | 1983 | 0.120 |
Why?
| Miniature Postsynaptic Potentials | 1 | 2014 | 9 | 0.120 |
Why?
| Ubiquitin-Specific Proteases | 1 | 2014 | 9 | 0.110 |
Why?
| COS Cells | 2 | 2006 | 185 | 0.110 |
Why?
| Pepstatins | 1 | 2014 | 4 | 0.110 |
Why?
| Pregnancy | 2 | 2018 | 6301 | 0.110 |
Why?
| I-kappa B Kinase | 1 | 2014 | 53 | 0.110 |
Why?
| Sequestosome-1 Protein | 1 | 2014 | 13 | 0.110 |
Why?
| Electrical Synapses | 1 | 2014 | 12 | 0.110 |
Why?
| Serum Albumin, Bovine | 1 | 2014 | 61 | 0.110 |
Why?
| Ubiquitin Thiolesterase | 1 | 2014 | 42 | 0.110 |
Why?
| Phosphoserine | 1 | 2014 | 33 | 0.110 |
Why?
| Muramidase | 1 | 2014 | 75 | 0.110 |
Why?
| RNA Interference | 2 | 2014 | 453 | 0.110 |
Why?
| RNA, Small Interfering | 2 | 2014 | 586 | 0.110 |
Why?
| Staurosporine | 1 | 2013 | 20 | 0.110 |
Why?
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2013 | 28 | 0.110 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 2 | 2014 | 166 | 0.110 |
Why?
| Gap Junctions | 1 | 2014 | 64 | 0.110 |
Why?
| Genes, Reporter | 1 | 2014 | 271 | 0.110 |
Why?
| Leucine | 1 | 2014 | 108 | 0.110 |
Why?
| Disease Models, Animal | 2 | 2021 | 4044 | 0.110 |
Why?
| GTPase-Activating Proteins | 1 | 2013 | 82 | 0.110 |
Why?
| Protease Inhibitors | 1 | 2014 | 105 | 0.100 |
Why?
| Heat-Shock Proteins | 1 | 2014 | 133 | 0.100 |
Why?
| Ventral Tegmental Area | 1 | 2013 | 50 | 0.100 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2014 | 158 | 0.100 |
Why?
| Statistics, Nonparametric | 1 | 2014 | 427 | 0.100 |
Why?
| Myosin Type I | 1 | 2012 | 1 | 0.100 |
Why?
| Cytoplasmic Vesicles | 1 | 2012 | 13 | 0.100 |
Why?
| Amphetamine-Related Disorders | 1 | 2013 | 36 | 0.100 |
Why?
| Glucose Transporter Type 4 | 1 | 2012 | 39 | 0.100 |
Why?
| Microtubule-Associated Proteins | 1 | 2014 | 191 | 0.100 |
Why?
| Cell Line, Transformed | 1 | 2012 | 141 | 0.100 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2011 | 3 | 0.100 |
Why?
| Cognition | 1 | 2019 | 1110 | 0.090 |
Why?
| Cocaine | 1 | 2013 | 150 | 0.090 |
Why?
| Tumor Suppressor Proteins | 1 | 2014 | 315 | 0.090 |
Why?
| Base Sequence | 3 | 2002 | 2162 | 0.090 |
Why?
| Solutions | 1 | 2011 | 148 | 0.090 |
Why?
| Mice, Transgenic | 1 | 2016 | 2107 | 0.090 |
Why?
| Oxidation-Reduction | 1 | 2014 | 1018 | 0.090 |
Why?
| Serine | 1 | 2011 | 137 | 0.090 |
Why?
| Alanine | 1 | 2011 | 142 | 0.090 |
Why?
| Seizures | 1 | 2014 | 396 | 0.090 |
Why?
| Muscle, Skeletal | 2 | 2003 | 1642 | 0.090 |
Why?
| Viral Fusion Proteins | 1 | 2010 | 20 | 0.090 |
Why?
| Gene Products, tat | 1 | 2010 | 22 | 0.090 |
Why?
| PC12 Cells | 1 | 2010 | 41 | 0.090 |
Why?
| Cell-Penetrating Peptides | 1 | 2010 | 19 | 0.090 |
Why?
| Receptors, Adrenergic, alpha-1 | 1 | 2010 | 44 | 0.080 |
Why?
| Conditioning, Classical | 1 | 2010 | 97 | 0.080 |
Why?
| Insulin | 2 | 2012 | 2322 | 0.080 |
Why?
| Patch-Clamp Techniques | 1 | 2010 | 265 | 0.080 |
Why?
| Electric Stimulation | 1 | 2010 | 269 | 0.080 |
Why?
| Immunohistochemistry | 5 | 2013 | 1711 | 0.080 |
Why?
| Rats, Wistar | 2 | 2007 | 399 | 0.080 |
Why?
| Cell Membrane | 1 | 2012 | 732 | 0.080 |
Why?
| In Vitro Techniques | 1 | 2010 | 1067 | 0.070 |
Why?
| Myocytes, Smooth Muscle | 1 | 2010 | 255 | 0.070 |
Why?
| Hydrogen-Ion Concentration | 1 | 2009 | 549 | 0.070 |
Why?
| Muscle, Smooth, Vascular | 1 | 2010 | 437 | 0.070 |
Why?
| Behavior, Animal | 1 | 2010 | 491 | 0.070 |
Why?
| Gene Expression | 2 | 2006 | 1487 | 0.070 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2006 | 4 | 0.070 |
Why?
| Mutant Proteins | 1 | 2006 | 98 | 0.060 |
Why?
| 2-Amino-5-phosphonovalerate | 1 | 2006 | 10 | 0.060 |
Why?
| Trinucleotide Repeats | 1 | 2006 | 26 | 0.060 |
Why?
| Subcellular Fractions | 1 | 2006 | 80 | 0.060 |
Why?
| Chickens | 1 | 2006 | 188 | 0.060 |
Why?
| Excitatory Amino Acid Antagonists | 1 | 2006 | 95 | 0.060 |
Why?
| Glycine | 1 | 2006 | 166 | 0.060 |
Why?
| Models, Biological | 3 | 2003 | 1716 | 0.060 |
Why?
| Amino Acid Substitution | 1 | 2006 | 287 | 0.060 |
Why?
| Immunoblotting | 3 | 2013 | 304 | 0.060 |
Why?
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 2 | 2014 | 15 | 0.060 |
Why?
| Proto-Oncogene Proteins c-raf | 1 | 2003 | 45 | 0.050 |
Why?
| Neurites | 1 | 2003 | 46 | 0.050 |
Why?
| Integrins | 1 | 2003 | 94 | 0.050 |
Why?
| Actinin | 1 | 2002 | 14 | 0.050 |
Why?
| Immunoprecipitation | 2 | 2014 | 160 | 0.050 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2003 | 316 | 0.050 |
Why?
| Stroke | 1 | 2010 | 1119 | 0.050 |
Why?
| Cloning, Molecular | 1 | 2002 | 536 | 0.050 |
Why?
| Islets of Langerhans | 1 | 2007 | 795 | 0.050 |
Why?
| Kidney | 2 | 2006 | 1343 | 0.050 |
Why?
| Cytoskeleton | 1 | 2001 | 180 | 0.040 |
Why?
| Ganglia | 1 | 1999 | 30 | 0.040 |
Why?
| Enzyme Induction | 1 | 1999 | 90 | 0.040 |
Why?
| Gene Expression Profiling | 1 | 2006 | 1714 | 0.040 |
Why?
| Prostatic Neoplasms | 1 | 2007 | 1004 | 0.040 |
Why?
| Microsomes | 1 | 1998 | 31 | 0.040 |
Why?
| Cell Compartmentation | 1 | 1998 | 52 | 0.040 |
Why?
| Organ Specificity | 1 | 1999 | 296 | 0.040 |
Why?
| Head | 1 | 1999 | 96 | 0.040 |
Why?
| Enzymes, Immobilized | 1 | 1998 | 29 | 0.040 |
Why?
| Amyloid beta-Protein Precursor | 1 | 2018 | 61 | 0.040 |
Why?
| Apoptosis | 1 | 2007 | 2519 | 0.040 |
Why?
| Calcium Signaling | 1 | 2019 | 237 | 0.040 |
Why?
| Biological Transport | 1 | 1998 | 397 | 0.040 |
Why?
| Spinal Cord | 1 | 1999 | 361 | 0.030 |
Why?
| Microscopy, Electron | 1 | 2017 | 421 | 0.030 |
Why?
| Microscopy, Immunoelectron | 1 | 2016 | 43 | 0.030 |
Why?
| Pseudopodia | 1 | 2016 | 22 | 0.030 |
Why?
| Protein Multimerization | 1 | 2017 | 180 | 0.030 |
Why?
| Microscopy, Confocal | 2 | 2010 | 309 | 0.030 |
Why?
| Fluorescence Resonance Energy Transfer | 1 | 2017 | 177 | 0.030 |
Why?
| Sarcomeres | 1 | 1996 | 92 | 0.030 |
Why?
| DNA, Complementary | 1 | 1996 | 271 | 0.030 |
Why?
| DNA Primers | 1 | 1996 | 523 | 0.030 |
Why?
| Ribosomal Protein S6 Kinases | 1 | 2014 | 21 | 0.030 |
Why?
| Deubiquitinating Enzyme CYLD | 1 | 2014 | 3 | 0.030 |
Why?
| Polyubiquitin | 1 | 2014 | 7 | 0.030 |
Why?
| Kainic Acid | 1 | 2014 | 34 | 0.030 |
Why?
| Ion Transport | 1 | 2014 | 57 | 0.030 |
Why?
| Tissue Culture Techniques | 1 | 2014 | 71 | 0.030 |
Why?
| Muscle Proteins | 1 | 1996 | 228 | 0.030 |
Why?
| Synaptic Membranes | 1 | 2013 | 17 | 0.030 |
Why?
| Cell Fractionation | 2 | 2003 | 56 | 0.030 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2014 | 146 | 0.030 |
Why?
| Dopamine Uptake Inhibitors | 1 | 2013 | 55 | 0.030 |
Why?
| Polyribosomes | 1 | 2013 | 22 | 0.030 |
Why?
| Conditioning, Operant | 1 | 2013 | 103 | 0.030 |
Why?
| Amphetamine | 1 | 2013 | 24 | 0.030 |
Why?
| Calcium Channels, L-Type | 1 | 2014 | 114 | 0.030 |
Why?
| Mice, Inbred BALB C | 1 | 1996 | 1245 | 0.030 |
Why?
| Time Factors | 3 | 2013 | 6615 | 0.030 |
Why?
| Rats, Long-Evans | 1 | 2013 | 118 | 0.030 |
Why?
| Potassium | 1 | 2013 | 140 | 0.030 |
Why?
| MAP Kinase Signaling System | 1 | 2014 | 311 | 0.020 |
Why?
| Exocytosis | 1 | 2012 | 89 | 0.020 |
Why?
| Dendrites | 1 | 2013 | 101 | 0.020 |
Why?
| Cytosol | 1 | 2012 | 211 | 0.020 |
Why?
| Neural Pathways | 1 | 2013 | 292 | 0.020 |
Why?
| Calcium-Binding Proteins | 1 | 2013 | 215 | 0.020 |
Why?
| Drug Interactions | 1 | 2013 | 370 | 0.020 |
Why?
| Lysine | 1 | 2014 | 278 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2013 | 766 | 0.020 |
Why?
| Endocytosis | 1 | 2012 | 163 | 0.020 |
Why?
| Gene Knockdown Techniques | 1 | 2012 | 320 | 0.020 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2014 | 385 | 0.020 |
Why?
| Central Nervous System Stimulants | 1 | 2013 | 159 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 1996 | 1207 | 0.020 |
Why?
| Up-Regulation | 1 | 2014 | 856 | 0.020 |
Why?
| Liver | 1 | 1999 | 1846 | 0.020 |
Why?
| Adrenergic alpha-1 Receptor Agonists | 1 | 2010 | 4 | 0.020 |
Why?
| Phenylephrine | 1 | 2010 | 75 | 0.020 |
Why?
| Calcineurin | 1 | 2010 | 91 | 0.020 |
Why?
| Receptors, GABA-A | 1 | 2010 | 96 | 0.020 |
Why?
| Thapsigargin | 1 | 2007 | 19 | 0.020 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2007 | 43 | 0.020 |
Why?
| Androgen Receptor Antagonists | 1 | 2007 | 36 | 0.020 |
Why?
| Luciferases | 1 | 2007 | 149 | 0.020 |
Why?
| Androstadienes | 1 | 2007 | 107 | 0.020 |
Why?
| Antibiotics, Antineoplastic | 1 | 2007 | 121 | 0.020 |
Why?
| Prostate-Specific Antigen | 1 | 2007 | 159 | 0.020 |
Why?
| Image Processing, Computer-Assisted | 1 | 2010 | 745 | 0.020 |
Why?
| Receptors, Androgen | 1 | 2007 | 146 | 0.020 |
Why?
| Androgens | 1 | 2007 | 174 | 0.020 |
Why?
| Doxorubicin | 1 | 2007 | 321 | 0.020 |
Why?
| Tumor Cells, Cultured | 1 | 2007 | 937 | 0.010 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 362 | 0.010 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 962 | 0.010 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 428 | 0.010 |
Why?
| Drug Therapy, Combination | 1 | 2007 | 1028 | 0.010 |
Why?
| Precipitin Tests | 1 | 2003 | 94 | 0.010 |
Why?
| Isoquinolines | 1 | 2003 | 42 | 0.010 |
Why?
| Organisms, Genetically Modified | 1 | 2003 | 14 | 0.010 |
Why?
| Fibronectins | 1 | 2003 | 119 | 0.010 |
Why?
| ras Proteins | 1 | 2003 | 151 | 0.010 |
Why?
| Immunosuppressive Agents | 1 | 2007 | 708 | 0.010 |
Why?
| Cell Proliferation | 1 | 2010 | 2381 | 0.010 |
Why?
| Luminescent Proteins | 1 | 2003 | 180 | 0.010 |
Why?
| HeLa Cells | 1 | 2003 | 607 | 0.010 |
Why?
| Cell Movement | 1 | 2003 | 948 | 0.010 |
Why?
| Bacterial Proteins | 1 | 2003 | 834 | 0.010 |
Why?
|
|
Bayer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|